Blood lipid levels in relation to glucose status in European men and women without a prior history of diabetes: The DECODE Study

Diabetes Research and Clinical Practice

Volumn 82, Issue 3, 2008, Pages 364-377

  Zhang, L ^a,b   Qiao, Q ^a,b   Tuomilehto, J ^a,b   Hammar, N ^c,d   Alberti, K G M M ^e   Eliasson, M ^f   Heine, R J ^g   Stehouwer, C D A ^h   Ruotolo, G ^d,i  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c KAROLINSKA INSTITUTE   (Sweden)

^d ASTRAZENECA R AND D   (Sweden)

^e ST MARY S HOSPITAL   (United Kingdom)

^f UMEÅ UNIVERSITY   (Sweden)

^g VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^h MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Cardiovascular disease; Diabetes; Impaired fasting glucose; Impaired glucose tolerance; Lipid

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 55549101235     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.08.022     Document Type: Article

References (37)

1. Wilson P.W. Established risk factors and coronary artery disease: the Framingham Study. Am. J. Hypertens. 7 (1994) 7S-12S
2. Kuller L.H., Velentgas P., Barzilay J., Beauchamp N.J., O'Leary D.H., and Savage P.J. Diabetes mellitus: subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 823-829
3. Tapp R.J., Balkau B., Shaw J.E., Valensi P., Cailleau M., and Eschwege E. Association of glucose metabolism, smoking and cardiovascular risk factors with incident peripheral arterial disease: the DESIR study. Atherosclerosis 190 (2007) 84-89
4. Laakso M., and Barrett-Connor E. Asymptomatic hyperglycemia is associated with lipid and lipoprotein changes favoring atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 9 (1989) 665-672
5. Barrett-Connor E., Grundy S.M., and Holdbrook M.J. Plasma lipids and diabetes mellitus in an adult community. Am. J. Epidemiol. 115 (1982) 657-663
6. Betteridge D.J. Diabetic dyslipidaemia. Eur. J. Clin. Invest. 29 Suppl. 2 (1999) 12-16
7. The DECODE Study Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch. Intern. Med. 161 (2001) 397-405
8. Meigs J.B., Nathan D.M., D'Agostino R.B., and Wilson P.W. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care 25 (2002) 1845-1850
9. Blake D.R., Meigs J.B., Muller D.C., Najjar S.S., Andres R., and Nathan D.M. Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: results from the Baltimore Longitudinal Study on Aging. Diabetes 53 (2004) 2095-2100
10. Novoa F.J., Boronat M., Saavedra P., Diaz-Cremades J.M., Varillas V.F., La Roche F., et al. Differences in cardiovascular risk factors, insulin resistance, and insulin secretion in individuals with normal glucose tolerance and in subjects with impaired glucose regulation: the Telde Study. Diabetes Care 28 (2005) 2388-2393
11. Morita S., Kasayama S., Otsuki M., Asanuma N., Saito H., Mukai M., et al. Atherosclerotic risk factors in Japanese subjects with isolated impaired fasting glucose and those with isolated impaired glucose tolerance according to 1997 and 2003 American Diabetes Association criteria. Diabetes Care 29 (2006) 2123-2126
12. Pankow J.S., Kwan D.K., Duncan B.B., Schmidt M.I., Couper D.J., Golden S., et al. Cardiometabolic risk in impaired fasting glucose and impaired glucose tolerance: the Atherosclerosis Risk in Communities Study. Diabetes Care 30 (2007) 325-331
13. The DECODE Study Group. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group. BMJ 317 (1998) 371-375
14. The DECODE Study Group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe. Lancet 354 (1999) 617-621
15. The DECODE Study Group. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 26 (2003) 61-69
16. The DECODE Study Group. Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. Diabetologia 49 (2006) 2837-2846
17. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 15 (1998) 539-553
18. Alberti K.G., Zimmet P., and Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 366 (2005) 1059-1062
19. De Backer G., Ambrosioni E., Borch-Johnsen K., Brotons C., Cifkova R., Dallongeville J., et al. European guidelines on cardiovascular disease prevention in clinical practice. Third joint task force of European and other Societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Atherosclerosis 173 (2004) 381-391
20. Rimm A.A., Hartz A., Kalbfleisch J.H., Anderson A.J., and Hoffmann RG. Basic Biostatistics in Medicine and Epidemiology (1980), Appleton-Century-Crofts, New York
21. Chen L.K., Lin M.H., Chen Z.J., Hwang S.J., Tsai S.T., and Chiou S.T. Metabolic characteristics and insulin resistance of impaired fasting glucose among the middle-aged and elderly Taiwanese. Diabetes Res. Clin. Pract. 71 (2006) 170-176
22. Harris S.B., Zinman B., Hanley A., Gittelsohn J., Hegele R., Connelly P.W., et al. The impact of diabetes on cardiovascular risk factors and outcomes in a native Canadian population. Diabetes Res. Clin. Pract. 55 (2002) 165-173
23. Avramoglu R.K., Basciano H., and Adeli K. Lipid and lipoprotein dysregulation in insulin resistant states. Clin. Chim. Acta 368 (2006) 1-19
24. Wasada T., Kuroki H., Katsumori K., Arii H., Sato A., and Aoki K. Who are more insulin resistant, people with IFG or people with IGT?. Diabetologia 47 (2004) 758-759
25. Bock G., Dalla Man C., Campioni M., Chittilapilly E., Basu R., Toffolo G., et al. Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 55 (2006) 3536-3549
26. Abdul-Ghani M.A., Tripathy D., and DeFronzo R.A. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29 (2006) 1130-1139
27. Meyer C., Pimenta W., Woerle H.J., Van Haeften T., Szoke E., Mitrakou A., et al. Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care 29 (2006) 1909-1914
28. Thomas G.N., Jiang C.Q., McGhee S.M., Zhang W.S., Lao X.Q., Schooling M., et al. Association of vascular risk factors with increasing glycemia even in normoglycemic subjects in an older Chinese population: the Guangzhou Biobank Cohort Study. Metabolism 55 (2006) 1035-1041
29. Howard B.V. Insulin resistance and lipid metabolism. Am. J. Cardiol. 84 (1999) 28J-32J
30. Katzmarzyk P.T., Janssen I., Ross R., Church T.S., and Blair S.N. The importance of waist circumference in the definition of metabolic syndrome: prospective analyses of mortality in men. Diabetes Care 29 (2006) 404-409
31. Onat A., Uyarel H., Hergenc G., Karabulut A., Albayrak S., Can G., et al. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study. Atherosclerosis 191 (2007) 182-190
32. Thomas G.N., Chook P., Qiao M., Huang X.S., Leong H.C., Celermajer D.S., et al. Deleterious impact of "high normal" glucose levels and other metabolic syndrome components on arterial endothelial function and intima-media thickness in apparently healthy Chinese subjects: the CATHAY study. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 739-743
33. Heiss G., Tamir I., Davis C.E., Tyroler H.A., Rifkand B.M., Schonfeld G., et al. Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study. Circulation 61 (1980) 302-315
34. Carroll M.D., Lacher D.A., Sorlie P.D., Cleeman J.I., Gordon D.J., Wolz M., et al. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA 294 (2005) 1773-1781
35. Arai H., Yamamoto A., Matsuzawa Y., Saito Y., Yamada N., Oikawa S., et al. Serum lipid survey and its recent trend in the general Japanese population in 2000. J. Atheroscler. Thromb. 12 (2005) 98-106
36. Abbott R.D., Garrison R.J., Wilson P.W., Epstein F.H., Castelli W.P., Feinleib M., et al. Joint distribution of lipoprotein cholesterol classes. The Framingham study. Arteriosclerosis 3 (1983) 260-272
37. Juutilainen A., Kortelainen S., Lehto S., Ronnemaa T., Pyorala K., and Laakso M. Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care 27 (2004) 2898-2904